Search research articles
Contact Us
Filters
Showing results (21-30 of 76) with videos related to
Page
of 8
Sort By:
Bulletin Du Cancer
|
June 4, 2010
[Cancer in Africa, a new health challenge. Examples of Mali and OncoMali]
M Ly, A Ly, M Rodrigues, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research
|
May 21, 2016
Skeletal-Related Events (SRES) Impact Significantly the Health-Related Quality of Life (HRQOL) of Chemo-Naive Men With Metastatic Castration Resistant Prostate Cancer (MCRPC)
C Ivanescu, D Phung, Y Loriot, et al.
British Journal of Cancer
|
July 15, 2010
BMS-690514, a VEGFR and EGFR tyrosine kinase inhibitor, shows anti-tumoural activity on non-small-cell lung cancer xenografts and induces sequence-dependent synergistic effect with radiation
Y Loriot, P Mordant, N Dorvault, et al.
European Journal of Cancer (Oxford, England : 1990)
|
December 15, 2018
Prognosis of renal cell carcinoma with bone metastases: Experience from a large cancer centre
F Ruatta, L Derosa, B Escudier, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
May 1, 2009
Diethylstilbestrol (DES) retains activity and is a reasonable option in patients previously treated with docetaxel for castration-resistant prostate cancer
C Serrate, Y Loriot, T De La Motte Rouge, et al.
Prostate Cancer and Prostatic Diseases
|
October 15, 2014
Who dies from prostate cancer?
A Patrikidou, Y Loriot, J-C Eymard, et al.
Bulletin Du Cancer
|
December 22, 2009
[New drugs in metastatic castration-resistant prostate cancer]
L Albiges, Y Loriot, M Gross-Goupil, et al.
BMC Cancer
|
March 1, 2016
Vimentin and Ki67 expression in circulating tumour cells derived from castrate-resistant prostate cancer
C R Lindsay, S Le Moulec, F Billiot, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
December 21, 2016
Impact of primary metastatic bone disease in germ cell tumors: results of an International Global Germ Cell Tumor Collaborative Group G3 Registry Study
C Oing, K Oechsle, A Necchi, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
July 25, 2009
Why do residents choose the medical oncology specialty? Implications for future recruitment--results of the 2007 French Association of Residents in Oncology (AERIO) Survey
Y Loriot, L Albiges-Sauvin, D Dionysopoulos, et al.
Page
of 8
Search research articles
Search
Showing results (21-30 of 76) with videos related to
Sort By:
Page
of 8
Bulletin Du Cancer
|
June 4, 2010
[Cancer in Africa, a new health challenge. Examples of Mali and OncoMali]
M Ly, A Ly, M Rodrigues, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research
|
May 21, 2016
Skeletal-Related Events (SRES) Impact Significantly the Health-Related Quality of Life (HRQOL) of Chemo-Naive Men With Metastatic Castration Resistant Prostate Cancer (MCRPC)
C Ivanescu, D Phung, Y Loriot, et al.
British Journal of Cancer
|
July 15, 2010
BMS-690514, a VEGFR and EGFR tyrosine kinase inhibitor, shows anti-tumoural activity on non-small-cell lung cancer xenografts and induces sequence-dependent synergistic effect with radiation
Y Loriot, P Mordant, N Dorvault, et al.
European Journal of Cancer (Oxford, England : 1990)
|
December 15, 2018
Prognosis of renal cell carcinoma with bone metastases: Experience from a large cancer centre
F Ruatta, L Derosa, B Escudier, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
May 1, 2009
Diethylstilbestrol (DES) retains activity and is a reasonable option in patients previously treated with docetaxel for castration-resistant prostate cancer
C Serrate, Y Loriot, T De La Motte Rouge, et al.
Prostate Cancer and Prostatic Diseases
|
October 15, 2014
Who dies from prostate cancer?
A Patrikidou, Y Loriot, J-C Eymard, et al.
Bulletin Du Cancer
|
December 22, 2009
[New drugs in metastatic castration-resistant prostate cancer]
L Albiges, Y Loriot, M Gross-Goupil, et al.
BMC Cancer
|
March 1, 2016
Vimentin and Ki67 expression in circulating tumour cells derived from castrate-resistant prostate cancer
C R Lindsay, S Le Moulec, F Billiot, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
December 21, 2016
Impact of primary metastatic bone disease in germ cell tumors: results of an International Global Germ Cell Tumor Collaborative Group G3 Registry Study
C Oing, K Oechsle, A Necchi, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
July 25, 2009
Why do residents choose the medical oncology specialty? Implications for future recruitment--results of the 2007 French Association of Residents in Oncology (AERIO) Survey
Y Loriot, L Albiges-Sauvin, D Dionysopoulos, et al.
Page
of 8